- Head of Multi-Asset Strategy - Insurance and Portfolio Manager
- About Us
- My Account
The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.
The investable asset universe for global insurers has evolved and proliferated rapidly and continues to do so. From new asset classes and security types to numerous implementation vehicles, keeping track of it all could easily be a full-time job. Within this vast universe resides a “galaxy” that is pretty large and eclectic in its own right: alternative investments. It’s an area that many investors (including some insurance companies) have historically taken a cautious stance on, but that has begun to change in recent years — an encouraging development, in our view.
One reason for the past skepticism was widespread confusion around the alternatives space. While traditional asset classes like equities and fixed income are familiar to and well understood by most investors, the alternatives bucket has chronically lacked a clear consensus, both in terms of the scope of the universe and what purpose it should serve in an investor’s strategic asset allocation. With that in mind, this paper aims to provide global insurers with a robust framework for how they might approach and navigate the alternative investments landscape. As prerequisites to using this framework, insurers should of course identify their own overall portfolio risk/return objectives and at least be open to the possibility that alternative investments can aid in the pursuit of those goals.
So how might insurers go about creating, implementing, and managing an effective alternative investments allocation? From where we sit, there should be four steps:
It’s safe to say that the umbrella overarching what constitutes an alternative investment is very broad and not of a “one-size-fits-all” variety. Even among insurers, there is little to no agreement or consistency. Some choose to include anything that is not public fixed income or public equity. Others opt to fold investment-grade-equivalent private fixed income and commercial mortgage loans into their fixed income bucket and not as alternatives, while others still may classify 144a bonds like securitized assets as alternatives. Simply put: The asset class has long been in dire need of a more uniform definition that insurers can latch onto. So, let’s address that first.
From an insurance standpoint, we believe there are four main types of investments that can/should be categorized as “alternatives” to public-market asset equivalents of core equities and fixed income (Figure 1).
The assets in this category share the fact that they are largely tangible investments with an intrinsic value tied to their substance and/or physical properties. In essence, investors acquire the underlying assets themselves as opposed to investing in financial contracts for ownership of the assets. The assets are incredibly diverse as shown in Figure 2, but there is significant overlap among them when it comes to how they might fit in an insurer’s overall asset allocation strategy. If properly integrated into such a strategy, real assets can potentially confer the following portfolio benefits:
This asset class has swiftly evolved from a niche allocation idea adopted by the largest life insurers, or a surplus investment idea for longer-duration non-life insurers, to a core portfolio holding for global insurers of all stripes. With more insurers now investing in or seriously considering the private-credit asset class, an understanding of exactly what investments it comprises is critical to how insurers should think about structuring their portfolios.
A little background: As most banks worldwide reduced lending activity post the 2008 financial crisis, private investment capital stepped in to fill the void. In 2000, total private-credit assets under management (AUM) were only around US$50 billion, but that figure had soared to over US$1 trillion by the end of 2020 — a roughly 20x increase! Global insurers have helped to fuel the rapid growth of this asset class and remain major participants in it, continuing to invest across the private-credit risk spectrum. For example, private placements as a percentage of total bonds outstanding have reached 40% for US life insurance companies and nearly 20% for both US health and P&C insurers (Figure 4).
In general, most insurers’ private-credit positions tend to skew toward the less risky side of the spectrum and, in the investment-grade bond sector, are similar in many ways to traditional public fixed income. However, it’s important to note that global insurers can (and some do) utilize private-credit assets not just for capital preservation and income generation, but also to boost their portfolios’ total-return potential if they are willing to accept the attendant risks of such assets (Figure 5).
If we break down the private-credit investment universe by anticipated levels of risk, you can begin to make portfolio allocation decisions based on some common characteristics:
1) Lowest potential risk (capital preservation focus):
2) Moderate potential risk (both capital preservation and total-return potential):
3) Higher potential risk (total-return potential):
Similar to private credit, private equity has also found a place in the invested assets of many global insurers. This should not come as a surprise, as the very nature of how companies approach going public versus staying private has changed considerably in recent years. Over the past two decades, there has been a growing trend of many companies remaining private for longer. Stepped-up industry regulation, favorable market dynamics for large-cap equities, and a recent history of strong post-initial public offering (IPO) performance for mature businesses have all contributed to this phenomenon of companies going public later in their life cycles and at larger sizes than in the past.
By way of further illustration, a quick look at the small-cap equity universe highlights the structural market shift toward the private-equity sphere. In 2001, the proportion of companies in the publicly traded small-cap Russell 2000 Index with market capitalizations of less than US$1 billion was 55%. By 2011, this number had fallen to 44%. As of year-end 2021, it was down to a mere 12%. The takeaway? While public-market opportunities have shrunk, the opportunity set in the private-equity market has expanded meaningfully and now consists of…
To read more, please click the download link below.
Alternative Investment OutlookContinue reading
Private credit: Key market themes for the year aheadContinue reading
Embracing uncertainty: Three alternatives ideas for a macro-driven worldContinue reading
Macro implications of the AI revolution: is the market right?Continue reading
Growth efficiency: The new venture capital regimeContinue reading
Private investing portfolio company interview with AMP Robotics CEOContinue reading
Supporting the next generation of entrepreneursContinue reading
Alternative Investment Outlook
This collection provides timely ideas across the spectrum of alternative investments -- including hedge funds, private equity, and private credit.
Private credit: Key market themes for the year ahead
In our annual private credit outlook, learn about three themes that have dominated headlines recently and may create opportunities for parts of the private credit market going forward.
Embracing uncertainty: Three alternatives ideas for a macro-driven world
Even as investors wrestle with the economic unknowns heading into 2024, Multi-Asset Strategists Nick Samouilhan and Adam Berger see opportunities to put alternative investments to work.
Macro implications of the AI revolution: is the market right?
Macro Strategist John Butler sets out an initial framework to help answer key questions about the potential macro impact of artificial intelligence.
Growth efficiency: The new venture capital regime
Frederik Groce, Deal Lead for Wellington Access Ventures, explores how the 'growth-at-any-cost' venture capital regime has shifted to a focus on growth efficiency, highlighting two key metrics for companies to keep top of mind.
Private investing portfolio company interview with AMP Robotics CEO
Dr. Matanya Horowitz, CEO of AMP Robotics, highlights how the company integrates AI and robotics into the recycling industry and explores the “actionable guidance” Wellington provides on ESG and other strategic issues.
Supporting the next generation of entrepreneurs
We highlight how Wellington Access Ventures, our early-stage VC platform, partners with historically underrepresented founders and offers the capital, resources, and networks that these companies have historically lacked.
Decoding impact expectations: best practices for impact investors and companies
We share three recommendations each for impact investors and companies to help them better understand and manage each other's expectations.
Private investing portfolio company interview with RayzeBio CEO Ken Song
Dr. Ken Song, President and CEO of RayzeBio, discusses the company’s innovative approach to radiopharmaceuticals and highlights how Wellington’s public and private investment expertise is distinctive in the health care space.
Why climate change matters in private markets
Private equity deep dive
We explore four key private equity questions to help investors better understand how these strategies compare and complement each other in a portfolio. In particular, we highlight the distinct opportunity sets, risk-return characteristics, and portfolio roles of venture capital and buyout strategies.